Seminar & Symposium/Admissions





講演者: 大倉 永也(大阪大学 免疫学フロンティア研究センター 実験免疫学 教授)

Title: Elimination of tumor-infiltrating regulatory T cells for enhancing anti-tumor immunity


日時: 2021年6月2日(水)12:00- 13:00

※ Zoom開催。URLはMoodleの「HIGO最先端セミナー」にてご確認ください。



Regulatory T (Treg) cells are a subgroup of CD4+ T cells essential for maintaining immune homeostasis, and repress aberrant and excessive immune responses. Based on these characteristics, Treg-control is considered to be effective in suppressing autoimmune diseases, and conversely, enhancing cancer immunity. Previous studies have shown that anti-tumor immune activity can be enhanced by removing Treg cells; however, systemic Treg elimination causes serious autoimmune diseases. We therefore analyzed the diversity of Treg cells using single-cell analysis platforms, and tried to identify a specific molecule of tumor-infiltrating Treg cells for enhancing anti-tumor immunity. By screening the molecule from tumors, we found that CCR8 was highly expressed in tumor-infiltrating Treg cells, but not in normal Treg and conventional T cells. As expected, anti-CCR8 antibody enhanced anti-tumor activity without any symptoms of autoimmune diseases in tumor-bearing mouse models. We hope that this molecule will become a promising target for cancer immunotherapy.



1) Immunity. 2020 Jun 16;52(6):1119-1132.e4.

2) Immunity. 2013 Mar 21;38(3):414-23.


担当分野:細胞医学 渡邉(内線:6804)


Copyright © Kumamoto University All Rights Reserved.